92 High-dimensional, single-cell analysis and transcriptional profiling reveal novel correlatives of response to PARP inhibition plus PD-1 blockade in triple-negative breast cancer
Alexander P. Gottlieb(Brigham and Women's Hospital), Jennifer L. Guerriero(Brigham and Women's Hospital), Janae Davis(Dana-Farber Cancer Institute), Elizabeth A. Mittendorf(Beth Israel Deaconess Medical Center), Tuulia Vallius(Harvard University), S. Church(Nanostring Technologies (United States)), Eric D. Miller(The Ohio State University), Joan S. Brugge(Harvard University), Alan D. D’Andrea(Dana-Farber Cancer Institute), Geoffrey I. Shapiro(Brigham and Women's Hospital), Clarence Yapp(Harvard University), Melinda L. Telli(Stanford University), Jia‐Ren Lin(Harvard University), Peter K. Sorger(Harvard University Press), Sara M. Tolaney(Harvard University), Ricardo Pastorello(Dana-Farber Cancer Institute), Anniina Färkkilä(University of Helsinki), Gregory J. Baker(University of California, Los Angeles), Giulia Fulci(Massachusetts General Hospital), Yuan Chen(Guangxi University of Chinese Medicine), Filipa Lynce(Institut Claudius Regaud), Shaveta Vinayak(Roswell Park Comprehensive Cancer Center), Sandro Santagata(Harvard University)
Cited by 1
Related Papers
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Copper induces cell death by targeting lipoylated TCA cycle proteins
|Science|2022|4.6k